Hansen Hh
- Oncology top 10%
- Lung Cancer Research Studies 16
- Peptidase Inhibition and Analysis 5
- Cancer Treatment and Pharmacology 3
-
- Pleural and Pulmonary Diseases 2
- Lung Cancer Diagnosis and Treatment 2
-
- Neuroendocrine Tumor Research Advances 13
-
- Neuroblastoma Research and Treatments 2
-
- Cancer therapeutics and mechanisms 6
- Co-authors
- P DombernowskyJoseph AisnerE BorkKell ØsterlindS SörensonFranco M. MuggiaMikael RørthKim S. Larsen
- Journals
- PubMed (35 papers)
- Partner nations
- DenmarkUnited States
In The Last Decade
Hansen Hh
34 papers receiving 454 citations
Peers
Comparison fields: 5 of 64
- Oncology 351
- Pulmonary and Respiratory Medicine 247
- Epidemiology 186
- Neurology 40
- Reproductive Medicine 22
Countries citing papers authored by Hansen Hh
This map shows the geographic impact of Hansen Hh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hansen Hh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hansen Hh more than expected).
Fields of papers citing papers by Hansen Hh
This network shows the impact of papers produced by Hansen Hh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hansen Hh. The network helps show where Hansen Hh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hansen Hh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomized trial of doxorubicin versus cyclophosphamide in diffuse malignant pleural mesothelioma. | 1985 | 67 |
| 2 | Radiotherapy of small cell lung cancer. An analysis with special reference to autopsy findings. | 1985 | 0 |
| 3 | Phase II study of teniposide in small cell carcinoma of the lung. | 1984 | 24 |
| 4 | Phase II trial of diaziquone in advanced renal adenocarcinoma. | 1984 | 2 |
| 5 | Phase II study of vindesine, cisplatin, and hexamethylmelamine (VCH) in small cell carcinoma of the lung. | 1984 | 4 |
| 6 | Treatment of small cell carcinoma of the lung. | 1984 | 1 |
| 7 | Phase II study of vinblastine in small cell carcinoma of the lung. | 1983 | 5 |
| 8 | Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung. | 1982 | 21 |
| 9 | Phase II study of procarbazine in small cell carcinoma of the lung. | 1982 | 11 |
| 10 | Commentary: current status of chemotherapy for non-small cell lung cancer. | 1982 | 72 |
| 11 | Phase II clinical trial of VP-16-213 in ovarian cancer. | 1981 | 24 |
| 12 | 5-FU in the treatment of small cell anaplastic carcinoma of the lung: a phase II trial. | 1981 | 6 |
| 13 | [Combination chemotherapy of the superior vena cava syndrome in small cell anaplastic lung carcinoma]. | 1980 | 2 |
| 14 | Functional analysis of organic sphincter systems by elastance-measurement. Evaluation of a new method. | 1979 | 1 |
| 15 | cis-Dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma: a phase II study. | 1979 | 19 |
| 16 | Unpredictable hematologic toxicity of weekly ddmp. | 1978 | 1 |
| 17 | Clinical trial of rubidazone in solid tumors and malignant lymphomas. | 1978 | 2 |
| 18 | Phase I clinical trial of a single-dose and two weekly schedules of ICRF-159 (NSC-129943). | 1974 | 7 |
| 19 | Should initial treatment of small cell carcinoma include systemic chemotherapy and brain irradiation? | 1973 | 73 |
| 20 | Treatment of malignant brain tumors with nitrosoureas. | 1971 | 11 |
About Hansen Hh
Hansen Hh is a scholar working on Oncology, Epidemiology, Pulmonary and Respiratory Medicine, Gastroenterology and Pharmaceutical Science, having authored 35 papers that have together received 539 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (16 papers), Neuroendocrine Tumor Research Advances (13 papers), Cancer therapeutics and mechanisms (6 papers), Peptidase Inhibition and Analysis (5 papers), Cancer Treatment and Pharmacology (3 papers), Pleural and Pulmonary Diseases (2 papers), Neuroblastoma Research and Treatments (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (351 citations), Pulmonary and Respiratory Medicine (247 citations), Epidemiology (186 citations), Neurology (40 citations) and Reproductive Medicine (22 citations). Hansen Hh has collaborated with scholars based in Denmark and United States. Frequent co-authors include P Dombernowsky, Joseph Aisner, E Bork, Kell Østerlind, S Sörenson, Franco M. Muggia, Mikael Rørth, Kim S. Larsen, Nissen Ni and Johannes Mejer. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.